Post-Transplantation Multicolored Flow Cytometry–Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia
Evgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, Ulrike Fritsche-Friedland, Dietlinde Janson, Francis Ayuk, Maximilian Christopeit, Christine Wolschke, Ulrike Bacher, Nicolaus Kröger
Topics & Concepts
MedicineInternal medicineTransplantationMyeloid leukemiaFludarabineMinimal residual diseaseUnivariate analysisRefractory (planetary science)CytarabineLeukemiaProportional hazards modelGastroenterologyOncologySurgeryMultivariate analysisChemotherapyAstrobiologyPhysicsCyclophosphamideAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia research